Investor Presentation
Company Overview
4DMedical origins & history
A fifteen year journey from conception to commercialisation
First commercial agreement to
collaborate with major US hospital signed
with Cedars Sinari
Andreas Fouras conceptualises 4D
imaging using X-rays
Andreas Fouras and colleagues receive an
American Asthma Foundation Research
Grant
First clinical studies using
XV Technology begin
510(k) FDA submission made
First major order received for a
preclinical scanner
Imaging complete for first phase of
clinical trial
Australian TGA
Approval for XV
LVAS
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Pg 15 | Investor presentation
First patent for XV Technology is filed
4DMedical commences operations
Agreement signed with
two more major US
hospitals
Clinical trial completed
Clinical Advisory Board is formed,
comprising of leaders in respiratory
diagnostics
First in human data released at the 2017
International Workshop on Pulmonary
Imaging
FDA clearance received for
XV LVAS
4DMedical™
FORMERLY 4DView entire presentation